Emerging Markets Regulatory Tracker: Brazil (Vol. 4 No. 63)
This article was originally published in PharmAsia News
Executive Summary
Brazil’s regulator issued a clarification on bioavailability studies for the marketing approval of fixed-dose generic drugs.